AccuVein has received $22.5 million in venture capital financing. MVM Life Science Partners and Bessemer Venture Partners led the financing round, while existing investors also participated.
The company intends to use the proceeds to continue its expansion into untapped markets and to enhance its focus on global customers. Eric Bednarski of MVM Life Science Partners and Christopher Gabrieli of Bessemer Venture Partners have joined the AccuVein board of directors.
Click here for the release from Business Wire.